| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $181K | -91.8% |
| Gross Profit | -$181K | +91.2% |
| R&D Expense | $175K | -90.4% |
| SG&A Expense | $13.3M | +51.6% |
| Operating Income | -$18.4M | -39.7% |
| Interest Expense | $472K | -85.9% |
| Pre-tax Income | -$79.1M | -129.1% |
| Income Tax | $0 | — |
| Net Income | -$79.1M | -129.1% |
| EPS (Basic) | -$2.25 | +61.9% |
| EPS (Diluted) | -$2.25 | +61.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.7M | — |
| Accounts Receivable | $0 | — |
| Inventory | $1.5M | +0.0% |
| Current Assets | $45.8M | +2311.6% |
| Total Assets | $49.8M | +614.8% |
| Current Liabilities | $61.4M | +195.4% |
| Long-term Debt | $25.5M | +175.5% |
| Total Liabilities | $65.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -143.2% |
| Capital Expenditures | $4.7M | — |
| Investing Cash Flow | -$16.7M | — |
| Financing Cash Flow | $58.1M | +1142.8% |
| Free Cash Flow | -$20.8M | — |
| +210.8% |
| Stockholders' Equity | -$15.2M | +59.9% |